Newborn screening is testing performed on newborn babies to detect a wide variety of disorders. Typically, testing is performed on a blood sample obtained from a heel prick when the baby is two or three days old. In the United States, newborn screening is mandatory for several different genetic disorders, though the exact set of required tests differs from state to state.
To play the media you will need to either update your browser to a recent version or update your Flash plugin
Newborn screening is biochemical testing that is done on a newborn to detect genetic disorders that are treatable, or in certain cases preventable, with appropriate medical care that's provided essentially right away. The testing is performed on a blood sample that's collected from a little pinprick on the baby's heel within the first few hours after [birth]. In the United States, newborn screening is mandatory in all 50 states and the territories. However, given a state mandate; each state may have a different list of conditions which newborn screening is required for.
Donald W. Hadley, M.S., C.G.C.
Associate Investigator, Social and Behavioral Research Branch, Public Health Genomics Section; Associate Director, Office of Clinical Liaison, Office of the Clinical Director
Mr. Hadley is a genetic counselor and a clinical researcher. As a genetic counselor, he provides education and counseling for people participating in NIH clinical protocols who have or at risk for inherited diseases. As a researcher, he evaluates methods for educating and counseling families with genetic conditions. His research is performed within the Public Health Genomics Section. Mr. Hadley strives to understand the psychological and behavioral outcomes of the counseling and testing process. His clinical role gives him insight into concerns of families considering genetic testing and the issues they deal with following their decisions.